lewis-x-antigen and Triple-Negative-Breast-Neoplasms

lewis-x-antigen has been researched along with Triple-Negative-Breast-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for lewis-x-antigen and Triple-Negative-Breast-Neoplasms

Article	Year
Spatial predictors of immunotherapy response in triple-negative breast cancer. Nature, 2023, Volume: 621, Issue:7980 Immune checkpoint blockade (ICB) benefits some patients with triple-negative breast cancer, but what distinguishes responders from non-responders is unclear Topics: B-Lymphocytes; Biopsy; CD8-Positive T-Lymphocytes; Granzymes; Histocompatibility Antigens Class II; Humans; Immunotherapy; Lewis X Antigen; Neoadjuvant Therapy; Precision Medicine; Prognosis; Randomized Controlled Trials as Topic; T-Lymphocytes; Triple Negative Breast Neoplasms	2023

Article

Year

Spatial predictors of immunotherapy response in triple-negative breast cancer.

Nature, 2023, Volume: 621, Issue:7980

Immune checkpoint blockade (ICB) benefits some patients with triple-negative breast cancer, but what distinguishes responders from non-responders is unclear

Topics: B-Lymphocytes; Biopsy; CD8-Positive T-Lymphocytes; Granzymes; Histocompatibility Antigens Class II; Humans; Immunotherapy; Lewis X Antigen; Neoadjuvant Therapy; Precision Medicine; Prognosis; Randomized Controlled Trials as Topic; T-Lymphocytes; Triple Negative Breast Neoplasms

2023